Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2011, Article ID 740583, 7 pages
http://dx.doi.org/10.4061/2011/740583
Review Article

Three Types of Striational Antibodies in Myasthenia Gravis

1Department of Neurology, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
2Department of Neurology, Hanamaki General Hospital, Hanamaki 025-0075, Japan

Received 28 April 2011; Accepted 3 June 2011

Academic Editor: Johan A. Aarli

Copyright © 2011 Shigeaki Suzuki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [41 citations]

The following is the list of published articles that have cited the current article.

  • Fredrik Romi, Shigeaki Suzuki, Norihiro Suzuki, Axel Petzold, Gordon T. Plant, and Nils Erik Gilhus, “Anti-voltage-gated potassium channel Kv1.4 antibodies in myasthenia gravis,” Journal of Neurology, vol. 259, no. 7, pp. 1312–1316, 2012. View at Publisher · View at Google Scholar
  • Matthew N. Meriggioli, and Donald B. Sanders, “Muscle autoantibodies in myasthenia gravis: Beyond diagnosis?,” Expert Review of Clinical Immunology, vol. 8, no. 5, pp. 427–438, 2012. View at Publisher · View at Google Scholar
  • Satoshi Kuwabara, “Clinical neurophysiology and immunology of E-C coupling of muscle,” Clinical Neurophysiology, vol. 123, no. 6, pp. 1065–1066, 2012. View at Publisher · View at Google Scholar
  • Lydia Sharp, and Steven Vernino, “Paraneoplastic neuromuscular disorders,” Muscle & Nerve, vol. 46, no. 6, pp. 841–850, 2012. View at Publisher · View at Google Scholar
  • Paola Cavalcante, Pia Bernasconi, and Renato Mantegazza, “Autoimmune mechanisms in myasthenia gravis,” Current Opinion in Neurology, vol. 25, no. 5, pp. 621–629, 2012. View at Publisher · View at Google Scholar
  • Shigeaki Suzuki, “New clinical entity of myasthenia gravis with autoimmune targets of heart and skeletal muscles,” Clinical Neurology, vol. 52, no. 11, pp. 1312–1314, 2012. View at Publisher · View at Google Scholar
  • Shigeaki Suzuki, Kimiaki Utsugisawa, and Norihiro Suzuki, “Overlooked non-motor symptoms in myasthenia gravis,” Journal of Neurology, Neurosurgery and Psychiatry, vol. 84, no. 9, pp. 959–994, 2013. View at Publisher · View at Google Scholar
  • Tomoya Kon, Fumiaki Mori, Kunikazu Tanji, Yasuo Miki, Tamaki Kimura, and Koichi Wakabayashi, “Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma,” Neuropathology, vol. 33, no. 3, pp. 281–287, 2013. View at Publisher · View at Google Scholar
  • Shigeaki Suzuki, Tetsuya Nishimoto, Mitsutomo Kohno, Kimiaki Utsugisawa, Yuriko Nagane, Masataka Kuwana, and Norihiro Suzuki, “Clinical and immunological predictors of prognosis for Japanese patients with thymoma-associated myasthenia gravis,” Journal Of Neuroimmunology, vol. 258, no. 1-2, pp. 61–66, 2013. View at Publisher · View at Google Scholar
  • Manabu Inoue, Yasuhiro Kojima, Masato Kinboshi, Tomokazu Nakagawa, Masutaro Kanda, and Hiroshi Shibasaki, “A case of myasthenia gravis presenting solely with bulbar palsy unassociated with easy fatigability,” Clinical Neurology, vol. 53, no. 3, pp. 229–234, 2013. View at Publisher · View at Google Scholar
  • Nuha M. Alkhawajah, and Joel Oger, “Late-onset myasthenia gravis: A review when incidence in older adults keeps increasing,” Muscle and Nerve, vol. 48, no. 5, pp. 705–710, 2013. View at Publisher · View at Google Scholar
  • Elham Bayat, and Henry J. Kaminskipp. 69–77, 2013. View at Publisher · View at Google Scholar
  • Betul Gundogdu, Myrna R. Rosenfeld, and Stacy A. Rudnickipp. 1501–1514, 2013. View at Publisher · View at Google Scholar
  • Masaharu Takamori, “Structural and pathogenic mechanisms centered on muscle-specific tyrosine kinase in autoimmune neuromuscular junction disorders,” Current Immunology Reviews, vol. 9, no. 4, pp. 207–213, 2013. View at Publisher · View at Google Scholar
  • Rosana Herminia Scola, Claudia Suemi Kamoi Kay, Lineu Cesar Werneck, Paulo Jose Lorenzoni, and Lucas Pires Augusto, “Myasthenia gravis and thymus: long-term follow-up screening of thymectomized and non-thymectomized patients,” Arquivos De Neuro-Psiquiatria, vol. 71, no. 7, pp. 462–464, 2013. View at Publisher · View at Google Scholar
  • Suzuki, Suzuki, Baba, Kaida, Utsugisawa, Kita, Tsugawa, Ogawa, Nagane, and Kuwana, “Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies,” European Journal of Neurology, vol. 21, no. 2, pp. 223–230, 2014. View at Publisher · View at Google Scholar
  • Melinee Frenkian-Cuvelier, and Bruno Eymard, “Diagnostic and clinical classification of autoimmune myasthenia gravis,” Journal of Autoimmunity, vol. 48-49, pp. 143–148, 2014. View at Publisher · View at Google Scholar
  • Poojita Shivamurthy, and Matthew W. Parker, “Cardiac manifestations of myasthenia gravis: A systematic review,” IJC Metabolic and Endocrine, vol. 5, pp. 3–6, 2014. View at Publisher · View at Google Scholar
  • Sivakumar Sathasivam, “Diagnosis and management of myasthenia gravis,” Progress in Neurology and Psychiatry, vol. 18, no. 1, pp. 6–14, 2014. View at Publisher · View at Google Scholar
  • Christian Probst, Sandra Saschenbrecker, Winfried Stoecker, and Lars Komorowski, “Anti-neuronal autoantibodies: Current diagnostic challenges,” Multiple Sclerosis and Related Disorders, vol. 3, no. 3, pp. 303–320, 2014. View at Publisher · View at Google Scholar
  • Masayuki Masuda, Kimiaki Utsugisawa, Shigeaki Suzuki, Jun-Ichi Kira, Hiroyuki Murai, Masakatsu Motomura, Shingo Konno, Yuriko Nagane, and Tomihiro Imai, “Clinical features and treatment status of adult myasthenia gravis in Japan,” Clinical and Experimental Neuroimmunology, vol. 5, no. 1, pp. 84–91, 2014. View at Publisher · View at Google Scholar
  • Wen-Mei Fan, Wei Wang, Yue-Min Li, and Yang Li, “Review on thymoma and thymoma-associated autoimmune diseases,” Medical Journal of Chinese People's Liberation Army, vol. 39, no. 8, pp. 669–672, 2014. View at Publisher · View at Google Scholar
  • Aliona Nacu, Jintana Bunpan Andersen, Vitalie Lisnic, Jone Furlund Owe, and Nils Erik Gilhus, “Complicating autoimmune diseases in myasthenia gravis: a review,” Autoimmunity, pp. 1–7, 2015. View at Publisher · View at Google Scholar
  • Alexander Shah, Pace, Hilton, Househam, and Weatherby, “Giant cell myositis responsive to combined corticosteroids and immunoglobulin,” Practical Neurology, vol. 15, no. 6, pp. 456–459, 2015. View at Publisher · View at Google Scholar
  • Stefanou, Kade, Komorowski, Bornemann, Ziemann, and Synofzik, “A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis,” BMC Neurology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Masaharu Takamori, “Structure and function of neuromuscular junction, centered on muscle-specific tyrosine kinase and related proteins,” Clinical and Experimental Neuroimmunology, vol. 7, no. 3, pp. 215–225, 2016. View at Publisher · View at Google Scholar
  • Yu Hong, Hai-Feng Li, Geir Olve Skeie, Fredrik Romi, Hong-Jun Hao, Xu Zhang, Xiang Gao, Jone Furlund Owe, and Nils Erik Gilhus, “Autoantibody profile and clinical characteristics in a cohort of Chinese adult myasthenia gravis patients,” Journal of Neuroimmunology, 2016. View at Publisher · View at Google Scholar
  • John D. Cullen, George M. Sachs, and Renee M. Hickey, “An overview of cardiac management in neuromuscular disease,” Open Cardiovascular Medicine Journal, vol. 10, pp. 82–88, 2016. View at Publisher · View at Google Scholar
  • Stéphane Mathis, Laurent Magy, Philippe Corcia, Karima Ghorab, Laurence Richard, Jonathan Ciron, Mathilde Duchesne, and Jean-Michel Vallat, “Simultaneous Combined Myositis, Inflammatory Polyneuropathy, and Overlap Myasthenic Syndrome,” Case Reports in Neurological Medicine, vol. 2016, pp. 1–11, 2016. View at Publisher · View at Google Scholar
  • Joachim Weis, Jörg B. Schulz, Kristl G. Claeys, Kathi Hartmann, Jens Reimann, Philip Van Damme, Isabell Cordts, Alain Vigneron, Socrates J. Tzartos, Nicolas Bodart, Katerina Karagiorgou, John S. Tzartos, Lin Mei, and Michael H. Rivner, “Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis,” Journal of Neurology, vol. 264, no. 6, pp. 1193–1203, 2017. View at Publisher · View at Google Scholar
  • Maxwell S. Damian, and Ravi Srinivasan, “Neuromuscular problems in the ICU,” Current Opinion in Neurology, vol. 30, no. 5, pp. 538–544, 2017. View at Publisher · View at Google Scholar
  • Jorge Rodríguez Prida, Luis Trapiella Martínez, and Aurora Astudillo González, “Giant cell myositis associated with myasthenia gravis and thymoma,” Medicina Clinica, vol. 151, no. 4, pp. 169, 2018. View at Publisher · View at Google Scholar
  • Lance J. Lyons, Sushma Yalamanchili, and Cynthia K. McClard, “Bilateral pseudo-internuclear ophthalmoplegia in a patient with myasthenia gravis,” American Journal of Ophthalmology Case Reports, vol. 12, pp. 76–78, 2018. View at Publisher · View at Google Scholar
  • Suresh C. Bokoliya, and Shripad A. Patil, “Assessment of pre and post-thymectomy myasthenia gravis,” Neurological Research, 2018. View at Publisher · View at Google Scholar
  • David S. Priemer, Sunil S. Badve, Darrell D. Davidson, and Patrick J. Loehrer, “Giant cell polymyositis and myocarditis in a patient with thymoma and myasthenia gravis: A postviral autoimmune process?,” Journal of Neuropathology and Experimental Neurology, vol. 77, no. 8, pp. 661–664, 2018. View at Publisher · View at Google Scholar
  • Maxwell S. Damian, “Myasthenia Gravis in the ICU,” Textbook of Neuroanesthesia and Neurocritical Care, pp. 41–50, 2019. View at Publisher · View at Google Scholar
  • Shinichi Otsu, Eiichiro Amano, Shigeaki Suzuki, and Akira Machida, “Eculizumab improved weakness and taste disorder in thymoma-associated generalized myasthenia gravis with anti-striational antibodies: A case report,” eNeurologicalSci, vol. 14, pp. 72–73, 2019. View at Publisher · View at Google Scholar
  • Yannick Kronimus, Richard Dodel, Sascha Neumann, and Sebastian P. Galuska, “IgG Fc N-glycosylation: Alterations in neurologic diseases and potential therapeutic target?,” Journal of Autoimmunity, vol. 96, pp. 14–23, 2019. View at Publisher · View at Google Scholar
  • Shirai, Sato, Sekijima, Kiniwa, Sano, Nakamura, Mikoshiba, Ohashi, and Okuyama, “Presence of antibodies to striated muscle and acetylcholine receptor in association with occurrence of myasthenia gravis with myositis and myocarditis in a patient with melanoma treated with an anti–programmed death 1 antibody,” European Journal of Cancer, vol. 106, pp. 193–195, 2019. View at Publisher · View at Google Scholar
  • Maxwell S. Damian, and Eelco F.M. Wijdicks, “The clinical management of neuromuscular disorders in intensive care,” Neuromuscular Disorders, 2019. View at Publisher · View at Google Scholar
  • Asako Onda, Shinji Miyagawa, Naoko Takahashi, Mina Gochi, Masamichi Takagi, Ichizo Nishino, Shigeaki Suzuki, Chizuko Oishi, and Hiroshi Yaguchi, “Pembrolizumab-induced Ocular Myasthenia Gravis with Anti-titin Antibody and Necrotizing Myopathy,” Internal Medicine, 2019. View at Publisher · View at Google Scholar